Reimagining patient-centric cancer clinical trials: a multi-stakeholder international coalition

Affiliations

• ¹ Memorial Sloan Kettering Cancer Center, Weill Cornell Medicine, New York, NY, USA. lib1@mskcc.org.
• ² Memorial Sloan Kettering Cancer Center, Weill Cornell Medicine, New York, NY, USA.
• ³ Princess Margaret Cancer Center, , University of Toronto, Toronto, Ontario, Canada.
• ⁴ Dana-Farber Brigham Cancer Center, Harvard Medical School, Boston, MA, USA.
• ⁵ Johns Hopkins Bloomberg School of Public Health, Baltimore, MD, USA.
• ⁶ Massachusetts General Hospital Cancer Center, Boston, MA, USA.
• ⁷ Society for Translational Oncology, Durham, NC, USA.
• ⁸ Oncology Center of Excellence, Food and Drug Administration, Silver Spring, MD, USA.
• ⁹ Cancer Support Community, Washington, DC, USA.
• ¹⁰ Foundation Medicine, Inc., Cambridge, MA, USA.
• ¹¹ Novartis, Basel, Switzerland.
• ¹² PPD, Inc., Wilmington, NC, USA.
• ¹³ Resolution Bioscience, Agilent Technologies, Kirkland, WA, USA.
• ¹⁴ McKinsey Cancer Center, McKinsey & Company.
• ¹⁵ Bloomberg New Economy, Bloomberg L.P., New York, NY, USA.
• ¹⁶ Asia Society Policy Institute, Asia Society, New York, NY, USA.
• ¹⁷ Daiichi Sankyo, Tokyo, Japan.
• ¹⁸ Innovent Biologics, Suzhou, China.
• ¹⁹ Janssen, Johnson and Johnson, New Brunswick, NJ, USA.
• ²⁰ BeiGene USA, BeiGene, Beijing, China.
• ²¹ Zai Lab, Shanghai, China.
• ²² Amgen, Inc, Thousand Oaks, CA, USA.
• ²³ Genentech, South San Francisco, CA, USA.
• ²⁴ Yale Cancer Center, Yale School of Medicine, New Haven, CT, USA.
• ²⁵ Jiangsu Hengrui Pharmaceuticals, Shanghai, China.
• ²⁶ Bayer AG, Leverkusen, Germany.
• ²⁷ Shanghai TuoXin Health Promotion Center, Shanghai, China.
• ²⁸ CEO Roundtable on Cancer, Morrisville, NC, USA.
• ²⁹ Guangdong Lung Cancer Institute, Guangdong Provincial People's Hospital, Guangdong Academy of Medical Sciences, Chinese Thoracic Oncology Group, Guangzhou, China.